Title: COMBAT Act of 2018
Policy area: Health

Summary:
Combating Opioid Misuse By Advancing Treatment Act of 2018 or the COMBAT Act of 2018
This bill requires the Government Accountability Office to conduct a study on best practices used by federal departments and agencies to reduce opioid use following a medical procedure that is conducted, funded, or otherwise supported by such agencies and departments.

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4903 Introduced in House (IH)]

<DOC>






115th CONGRESS
  2d Session
                                H. R. 4903

   To direct the Comptroller General to conduct a study and submit a 
report to Congress on best practices in use by Federal departments and 
     agencies to reduce opioid usage following medical procedures.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                            January 30, 2018

Mr. Kustoff of Tennessee (for himself and Mr. Norcross) introduced the 
   following bill; which was referred to the Committee on Energy and 
                                Commerce

_______________________________________________________________________

                                 A BILL


 
   To direct the Comptroller General to conduct a study and submit a 
report to Congress on best practices in use by Federal departments and 
     agencies to reduce opioid usage following medical procedures.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Combating Opioid Misuse By Advancing 
Treatment Act of 2018'' or the ``COMBAT Act of 2018''.

SEC. 2. STUDY ON BEST PRACTICES IN USE BY FEDERAL GOVERNMENT TO REDUCE 
              OPIOID USAGE FOLLOWING MEDICAL PROCEDURES.

    (a) Study.--The Comptroller General of the United States, in 
consultation with the Secretary of Health and Human Services, the 
Secretary of Defense, the Administrator of the Centers for Medicare & 
Medicaid Services, the Director of the National Institutes of Health, 
and the Commissioner of Food and Drugs, shall conduct a study on best 
practices in use by Federal departments and agencies to reduce opioid 
usage following a medical procedure that is conducted, funded, or 
otherwise supported by such departments and agencies.
    (b) Topics.--The study required by subsection (a)--
            (1) shall--
                    (A) include analysis of the research that has been, 
                and is being, conducted or supported on reducing opioid 
                usage following medical procedures described in 
                subsection (a);
                    (B) disaggregate such analysis according to whether 
                the medical procedure is a short-term medical procedure 
                or a long-term medical procedure; and
                    (C) take into consideration--
                            (i) the costs associated with using the 
                        best practices described in subsection (a) 
                        relative to the costs of not using such best 
                        practices; and
                            (ii) the rates of addiction to opioids 
                        associated with using the best practices 
                        described in subsection (a) relative to the 
                        rates of addiction to opioids associated with 
                        not using such best practices; and
            (2) shall include analysis of--
                    (A) gaps that have been identified by Federal 
                officials with respect to the costs and rates described 
                in clauses (i) and (ii) of paragraph (1)(C) relative to 
                adult, young adult, and adolescent populations; and
                    (B) justifications offered by such officials for 
                such gaps.
    (c) Report.--Not later than 2 years after the date of enactment of 
this Act, the Comptroller General shall submit to the appropriate 
committees of the Congress a report containing the results of the study 
conducted under subsection (a), including--
            (1) a summary of the findings of the study;
            (2) recommendations based on the results of the study, 
        including recommendations for such areas of research and 
        legislative and administrative action as the Comptroller 
        General determines appropriate; and
            (3) recommendations on educating health care providers 
        about the findings of the study.
    (d) Definitions.--In this Act:
            (1) The term ``short-term medical procedure'' means a 
        medical procedure with a recovery time of less than 30 calendar 
        days.
            (2) The term ``long-term medical procedure'' means a 
        medical procedure with a recovery time of 30 calendar days or 
        more.
                                 <all>